Navigation Links
Resistant Influenza strains creates panic in US

Rick A. Bright, an immunologist at the U.S. Centers for Disease Control and Prevention said that all samples of seasonal influenza virus this year have developed // resistance to adamantanes, the class of drugs which is used for the treatment for flu infection.

Drugs belonging to this class like amantadine and rimantadine are ineffectual for now and for the foreseeable future and shouldn't be used.

The findings were reported in the Journal of the American Medical Association. Amantadine and rimantadine were the pivotal drugs used against influenza A.

Statistics show that about 10-15% of the U.S. population suffers due to flu every year, and about 31,000 people die of it. Vaccination is considered the best strategy to prevent infection.

It was found that 91% of the 120 influenza a virus samples that were tested were resistant to these two drugs.

Presently a total of 209 influenza isolates (including the original 120) from 26 states across the United States were collected and analyzed. Overall resistance was found to be 92 %.

The researchers were very surprised at the speed with which the influenza strains develop the resistance. They feel that this is due to the widespread, over-the-counter and unregulated use of the drugs in other countries.

Tamiflu (oseltamivir) and Relenza (zanamivir) both the antiviral drugs belong to the neuraminidase inhibitor class of antivirals. The virus has not developed resistance against this class of drugs and hence can be used. But researchers fear that people will be using them more and might begin using them inappropriately and, with increased and inappropriate use, this will also become ineffective against the virus.

The researchers feel that there is an increased necessity for more energy and resources to be devoted to develop new antiviral drugs. In the end they conclude by saying that vaccines are the true way to protect oneself against influenz a.


'"/>




Related medicine news :

1. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
2. Hope for Chemo-Resistant Leukemia Patients
3. Understanding Gene Profiles Could Help Cure A Resistant Form Of Leukemia In Kids
4. HIV Virus Emerging Drug Resistant In UK, Prompting Fear Of A Second Epidemic
5. 90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose
6. Treatment Resistant Tumors Can Be Targeted Better Using Botox
7. New Drug Promises Hope In Multiple Drug Resistant And Latent TB Treatment
8. ‘Drug Resistant TB’ Rattles the Union Ministy
9. Malaria Resistant Mosquitoes Could Help In Combating Malaria
10. Tumor Resistant Mice Point To Novel Cancer Treatments
11. Mad-Cow Resistant Calf Cloned in China
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... ... Therapy continues to prove the safety and efficacy of HBOT in treating and ... across the US, points to research showing the similarities of the wounds to ...
(Date:8/23/2017)... TX (PRWEB) , ... August 23, 2017 , ... ... in the healthcare industry, made the 2017 Inc. 5000 with a three-year ... of the nation’s fastest-growing private companies and comprises the most comprehensive look at ...
(Date:8/23/2017)... ... August 23, 2017 , ... MobilityWorks ®, ... named to the 2017 Inc. 500|5000, an exclusive ranking of America’s fastest-growing private ... of 139 percent, marking the twelfth year that the company has been included ...
(Date:8/23/2017)... ... 23, 2017 , ... A new literature review ... points out that therapeutic modalities (physical therapy) is an important part of the ... a wider scope of physical therapy options is showing promising results and supports ...
(Date:8/22/2017)... ... August 22, 2017 , ... The old adage ... as simple as eating healthy foods. But this well-known piece of nutrition advice ... or breaking apart carbohydrates—depends not only on properties of the food but also ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 15, 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO), ... Michigan residents. Naloxone is available ... retail pharmacy, G-3320 Beecher Road. ... and Drug Administration, is intended to block or reverse ... and loss of consciousness. The medication is often carried ...
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 ... from continuing operations Second-quarter ... $110 million Second-quarter 2017 ... Second-quarter 2017 adjusted diluted ... percent to $0.93 Second-quarter ...
Breaking Medicine Technology: